Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
For almost 30 years, the National Cancer Institute (NCI) has sponsored health-related quality-of-life (HRQOL) measures in cancer research as a means of including the patient's experience. The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations.
Minasian
Lori M
LM
Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-7340, USA. minasilo@mail.nih.gov
O'Mara
Ann M
AM
Reeve
Bryce B
BB
Denicoff
Andrea M
AM
Kelaghan
Joseph
J
Rowland
Julia H
JH
Trimble
Edward L
EL
D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D006801:Humans; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000628:therapy*; D017060:Patient Satisfaction; D011367:Professional Staff Committees; D019984:Quality Indicators, Health Care; D011788:Quality of Life; D018434:Sickness Impact Profile; D016896:Treatment Outcome; D014481:United States